Susquehanna International Group’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11,607
| Closed | -$102K | – | 6790 |
|
|
2024
Q2 | $102K | Sell |
11,607
-5,824
| -33% | -$51.3K | ﹤0.01% | 5091 |
|
|
2024
Q1 | $153K | Buy |
17,431
+1,860
| +12% | +$16.3K | ﹤0.01% | 4824 |
|
|
2023
Q4 | $116K | Buy |
15,571
+3,405
| +28% | +$25.4K | ﹤0.01% | 5284 |
|
|
2023
Q3 | $70K | Buy |
12,166
+11,468
| +1,643% | +$65.9K | ﹤0.01% | 5028 |
|
|
2023
Q2 | $5.03K | Buy |
+698
| New | +$5.03K | ﹤0.01% | 5487 |
|
|
2023
Q1 | – | Sell |
-1,294
| Closed | -$8.64K | – | 6851 |
|
|
2022
Q4 | $8.64K | Buy |
+1,294
| New | +$8.64K | ﹤0.01% | 5493 |
|
|
2022
Q3 | – | Sell |
-834
| Closed | -$10K | – | 7071 |
|
|
2022
Q2 | $10K | Buy |
834
+114
| +16% | +$1.37K | ﹤0.01% | 5502 |
|
|
2022
Q1 | $15K | Sell |
720
-94
| -12% | -$1.96K | ﹤0.01% | 5515 |
|
|
2021
Q4 | $49K | Buy |
+814
| New | +$49K | ﹤0.01% | 5473 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6244 |
|